2nd Quarter - Report

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Firm
Client
Income
—
Expenses
$980,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.

LobbyistCovered position, as disclosed
GREGG HAIFLEY —
VICTORIA SENG —
RICHARD WOODRUFF —

Contacted: Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; White House Office; Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); State, Dept of (DOS)

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Qualityof Life Act;H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.5145 & S.2622, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, the Sunscreen Innovation Act, and regulations relating to tanning beds.

Contacted: White House Office; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); SENATE; Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA)

Bills named: S. 2622 (113th), S. 1247 (113th), S. 2141 (113th), S. 641 (113th), H.R. 2058 (113th), S. 1251 (113th), H.R. 2607 (113th), H.R. 2019 (113th), H.R. 460 (113th), H.R. 5145 (113th), H.R. 4250 (113th), H.R. 1339 (113th), S. 621 (113th), H.R. 1666 (113th)

Medicare/Medicaid MMM

Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070 & S.2348, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act, S.1871, the SGR Repeal & Medicare Beneficiary Access Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.

LobbyistCovered position, as disclosed
SARAH BOGDAN —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
KATRINA KAMM —
PATRICIA MALLIOS —
MATTHEW PHELAN —
VICTORIA SENG —
MONA SHAH —
RICHARD WOODRUFF —

Contacted: SENATE; Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); State, Dept of (DOS); White House Office; Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); U.S. Agency for International Development (USAID)

Bills named: H.R. 2810 (113th), H.R. 1070 (113th), S. 2348 (113th), S. 2157 (113th), S. 1871 (113th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and global health. President Obama's FY15 budget, S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; and H.R.3547, Omnibus Appropriations for FY14, andmatters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer. Also, H.Con.Res. 96, House-passed budget for FY15, and un-numbered House & Senate Labor-HHS Appropriations drafts for FY15.

Contacted: U.S. Agency for International Development (USAID); SENATE; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Labor, Dept of (DOL); White House Office; State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Bills named: S. 1284 (113th), H.R. 3547 (113th), H.Con.Res. 96 (113th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations: (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and PreventionAmerica Act, H.R.792 & S.772, cigar exemption from FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.

Contacted: Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; White House Office; U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC)

Bills named: S. 772 (113th), S. 194 (113th), H.R. 792 (113th), S. 39 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.